MNPR - Monopar Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MNPR is currently covered by 1 analysts with an average price target of $161.93. This is a potential upside of $63.36 (64.28%) from yesterday's end of day stock price of $98.57.

Monopar Therapeutics's activity chart (see below) currently has 9 price targets and 12 ratings on display. The stock rating distribution of MNPR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 822 days.

Highest price target for MNPR is $35, Lowest price target is $34.

Most recent stock forecast was given by SEAN LEE from HC WAINWRIGHT on 12-Aug-2024. First documented stock forecast 03-Feb-2020.

Best performing analysts who are covering MNPR - Monopar Therapeutics:

Sean Lee Jason Mccarthy Soumit Roy

Currently out of the existing stock ratings of MNPR, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$10

$-89.39 (-89.94%)

$10

1 years 1 months 26 days ago
(12-Aug-2024)

4/4 (100%)

$7.64 (323.73%)

648

Buy

$55

2 years 6 months 9 days ago
(29-Mar-2023)

1/1 (100%)

$29.95 (119.56%)

1818

Buy

$200

$100.61 (101.23%)

$200

5 years 3 months 22 days ago
(16-Jun-2020)

0/2 (0%)

$152.5 (321.05%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MNPR (Monopar Therapeutics) average time for price targets to be met?

On average it took 822 days on average for the stock forecasts to be realized with a an average price target met ratio 66.67

Which analyst has the current highest performing score on MNPR (Monopar Therapeutics) with a proven track record?

SEAN LEE

Which analyst has the current lower performing score on MNPR (Monopar Therapeutics) with a proven track record?

SOUMIT ROY

Which analyst has the most public recommendations on MNPR (Monopar Therapeutics)?

Sean Lee has 10 price targets and 8 ratings on MNPR

Which analyst is the currently most bullish on MNPR (Monopar Therapeutics)?

Soumit Roy with highest potential upside - $100.61

Which analyst is the currently most reserved on MNPR (Monopar Therapeutics)?

Sean Lee with lowest potential downside - -$89.39

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?